Business Description
Transcenta Holding Ltd
ISIN : KYG9005B1041
Compare
Compare
Traded in other countries / regions
06628.Hong Kong IPO Date
2021-09-29Description
Transcenta Holding Ltd is a clinical-stage biopharmaceutical company with fully integrated capacities in discovery, research, development, and manufacturing. It is developing nine therapeutic antibody molecules for oncology and selected non-oncology indications including bone and kidney disorders. Geographically the company operates in China (the PRC) and the USA.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.33 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.4 | |||||
| Debt-to-EBITDA | -0.93 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -3.01 | |||||
| Beneish M-Score | -2.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -12.4 | |||||
| 3-Year EBITDA Growth Rate | -14.4 | |||||
| 3-Year EPS without NRI Growth Rate | -13.8 | |||||
| 3-Year FCF Growth Rate | -16.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.94 | |||||
| 9-Day RSI | 45.56 | |||||
| 14-Day RSI | 45.85 | |||||
| 6-1 Month Momentum % | -62.33 | |||||
| 12-1 Month Momentum % | -73.27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.23 | |||||
| Quick Ratio | 1.2 | |||||
| Cash Ratio | 0.99 | |||||
| Days Inventory | 192.54 | |||||
| Days Sales Outstanding | 305.04 | |||||
| Days Payable | 602.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.8 | |||||
| Shareholder Yield % | 2.41 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 26.74 | |||||
| Operating Margin % | -861.5 | |||||
| Net Margin % | -859.01 | |||||
| FCF Margin % | -694.17 | |||||
| ROE % | -36.81 | |||||
| ROA % | -23.92 | |||||
| ROIC % | -30.38 | |||||
| ROC (Joel Greenblatt) % | -99.56 | |||||
| ROCE % | -32.33 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 12.28 | |||||
| PB Ratio | 0.69 | |||||
| Price-to-Tangible-Book | 1.53 | |||||
| EV-to-EBIT | -1.28 | |||||
| EV-to-EBITDA | -1.3 | |||||
| EV-to-Revenue | 10.59 | |||||
| EV-to-FCF | -1.53 | |||||
| Price-to-Net-Current-Asset-Value | 35.6 | |||||
| Earnings Yield (Greenblatt) % | -78.13 | |||||
| FCF Yield % | -52.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Transcenta Holding Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 58.899 | ||
| EPS (TTM) (HK$) | -1.247 | ||
| Beta | 0 | ||
| Volatility % | 41.6 | ||
| 14-Day RSI | 45.85 | ||
| 14-Day ATR (HK$) | 0.136195 | ||
| 20-Day SMA (HK$) | 1.751 | ||
| 12-1 Month Momentum % | -73.27 | ||
| 52-Week Range (HK$) | 1.17 - 5.72 | ||
| Shares Outstanding (Mil) | 435.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Transcenta Holding Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Transcenta Holding Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Transcenta Holding Ltd Frequently Asked Questions
What is Transcenta Holding Ltd(HKSE:06628)'s stock price today?
The current price of HKSE:06628 is HK$1.78. The 52 week high of HKSE:06628 is HK$5.72 and 52 week low is HK$1.17.
When is next earnings date of Transcenta Holding Ltd(HKSE:06628)?
The next earnings date of Transcenta Holding Ltd(HKSE:06628) is 2024-05-20 Est..
Does Transcenta Holding Ltd(HKSE:06628) pay dividends? If so, how much?
Transcenta Holding Ltd(HKSE:06628) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers